Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-64

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 64 Last

Share
Profile

Follow
ozgoldtrader

6,317 Posts.

216

06/07/22

16:10

Post #: 62404318
Share

Originally posted by Taurean7: ↑

RAP traded in the price range 8.6c – 9.4c on the day immediately prior to receiving the Pfizer bid. Since that day the Company has received:

1) $4M in funding to jointly develop a Covid mass-scanning device from a company with regulatory influence and global commercialisation infrastructure;
2) global exposure and recognition on the standing of its unique diagnostic technologies;
3) patent approvals in Australia and Japan covering enhancement of its ResAppDx and ResAppCc cough detection devices; and
4) FDA approval to open up the US market for its sleep apnoea scanning device.

Once the share price becomes unrestricted through a successful No vote, in which direction do you really think it will head @ozgoldtrader ?

Expand

I like your question at the end,

The more good news happens before the vote, the higher the chance SP will rise > could be the answer. -

Fattchoi’s theory also good, bit of that too.

RAP Price at posting: 13.3¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump is President Again: What Does This Mean for Crypto?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

First 64 Last

Add RAP (ASX) to my watchlist